Aadi Bioscience Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
AADI Nasdaq 2834 https://aadibio.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Aadi Bioscience Inc

Aadi Bioscience to Report Fourth Quarter and Full-Year 2022 Results and Corporate Update - Mar 15th, 2023 12:00 pm
Aadi Bioscience Announces Leadership Transition - Mar 3rd, 2023 1:00 pm
Aadi Bioscience to Present at the 43rd Annual Cowen Healthcare Conference - Feb 22nd, 2023 1:00 pm
Aadi Bioscience Presents PRECISION 1 Trial in Progress Poster and AMPECT Trial Final Analysis at the Connective Tissue Oncology Society (CTOS) 2022 Annual Meeting - Nov 17th, 2022 1:00 pm
Aadi Bioscience Announces Financial Results for the Third Quarter of 2022 and Provides Corporate Update - Nov 9th, 2022 1:00 pm
Aadi Bioscience Announces Planned Leadership Transition - Nov 8th, 2022 9:00 pm
Aadi Bioscience to Present at Upcoming Investor Conferences - Nov 3rd, 2022 12:00 pm
Aadi Bioscience Announces Improved Anti-Tumor Activity of KRAS Inhibitors in Combination with Nab-sirolimus at the 34th EORTC-NCI-AACR Symposium - Oct 27th, 2022 12:00 pm
Mirati Therapeutics and Aadi Bioscience Partner to Evaluate the Combination of Adagrasib with Nab-sirolimus in Patients with Advanced Non-Small Cell Lung Cancer and Other Solid Tumors with a KRAS[G12C] Mutation - Oct 12th, 2022 12:00 pm
Aadi Bioscience Announces $72.5 Million Private Placement Equity Financing - Sep 22nd, 2022 8:01 pm
Aadi Bioscience Announces Participation in Upcoming September Investor Conferences - Sep 1st, 2022 12:00 pm
Aadi Bioscience Announces Financial Results for the Second Quarter of 2022 and Provides Corporate Update - Aug 10th, 2022 12:00 pm
Is Aadi Bioscience, Inc. (NASDAQ:AADI) Popular Amongst Insiders? - Aug 4th, 2022 10:21 am
Aadi Bioscience to Report Second Quarter 2022 Results and Corporate Update - Jul 28th, 2022 12:30 pm
Aadi Bioscience to Join Russell 2000® and Russell 3000® Indexes - Jun 23rd, 2022 12:00 pm
Aadi Bioscience to Present at the Jefferies Global Healthcare Conference - Jun 1st, 2022 12:00 pm
Aadi Bioscience Appoints Marcy Graham Senior Vice President Investor Relations and Corporate Communications - May 31st, 2022 12:00 pm
Aadi Bioscience Announces Exploratory Biomarker Data from Patients in Its AMPECT Trial and Expanded Access Program to be Presented at 2022 ASCO Annual Meeting - May 26th, 2022 9:10 pm
Aadi Bioscience to Present at the H.C. Wainwright Global Investment Conference - May 18th, 2022 11:00 am
UPDATE -- Aadi Bioscience Reports First Quarter 2022 Financial Results and Provides a Corporate Update - May 12th, 2022 12:32 pm